MXCT logo

MaxCyte (MXCT) Cash From Operations

Annual CFO

-$21.69 M
-$6.90 M-46.70%

December 31, 2023


Summary


Performance

MXCT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMXCTcash flowmetrics:

Quarterly CFO

-$4.39 M
+$443.00 K+9.16%

September 30, 2024


Summary


Performance

MXCT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMXCTcash flowmetrics:

TTM CFO

-$18.81 M
+$3.85 M+16.98%

September 30, 2024


Summary


Performance

MXCT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMXCTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MXCT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.7%+46.7%+34.6%
3 y3 years-146.9%+27.9%-27.2%
5 y5 years-106.8%+27.9%-27.2%

MXCT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-103.1%at low-547.6%+58.4%-324.9%+34.6%
5 y5-year-146.9%at low-547.6%+58.4%-324.9%+34.6%
alltimeall time<-9999.0%at low-547.6%+58.4%-324.9%+34.6%

MaxCyte Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.39 M(-9.2%)
-$18.81 M(-17.0%)
Jun 2024
-
-$4.83 M(-54.2%)
-$22.66 M(-18.9%)
Mar 2024
-
-$10.56 M(-1176.9%)
-$27.93 M(+28.8%)
Dec 2023
-$21.69 M(+46.7%)
$981.00 K(-111.9%)
-$21.69 M(-24.6%)
Sep 2023
-
-$8.24 M(-18.5%)
-$28.75 M(+8.8%)
Jun 2023
-
-$10.11 M(+133.7%)
-$26.44 M(+71.5%)
Mar 2023
-
-$4.32 M(-29.0%)
-$15.41 M(+4.3%)
Dec 2022
-$14.78 M(+38.4%)
-$6.09 M(+2.8%)
-$14.78 M(+53.1%)
Sep 2022
-
-$5.92 M(-744.6%)
-$9.66 M(+118.2%)
Jun 2022
-
$918.60 K(-124.9%)
-$4.43 M(-54.5%)
Mar 2022
-
-$3.69 M(+284.7%)
-$9.73 M(-8.9%)
Dec 2021
-$10.68 M
-$960.30 K(+39.1%)
-$10.68 M(+9.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$690.50 K(-84.3%)
-$9.72 M(+7.6%)
Jun 2021
-
-$4.39 M(-5.5%)
-$9.03 M(+94.5%)
Mar 2021
-
-$4.64 M
-$4.64 M
Dec 2020
-$8.78 M(-0.2%)
-
-
Dec 2019
-$8.80 M(-16.1%)
-
-
Dec 2018
-$10.49 M(+8.4%)
-
-
Dec 2017
-$9.68 M(+314.4%)
-
-
Dec 2016
-$2.33 M(+1193.6%)
-
-
Dec 2015
-$180.50 K(-90.6%)
-
-
Dec 2014
-$1.93 M(+245.2%)
-
-
Dec 2013
-$557.80 K(-73.8%)
-
-
Dec 2012
-$2.13 M
-
-

FAQ

  • What is MaxCyte annual cash flow from operations?
  • What is the all time high annual CFO for MaxCyte?
  • What is MaxCyte annual CFO year-on-year change?
  • What is MaxCyte quarterly cash flow from operations?
  • What is the all time high quarterly CFO for MaxCyte?
  • What is MaxCyte quarterly CFO year-on-year change?
  • What is MaxCyte TTM cash flow from operations?
  • What is the all time high TTM CFO for MaxCyte?
  • What is MaxCyte TTM CFO year-on-year change?

What is MaxCyte annual cash flow from operations?

The current annual CFO of MXCT is -$21.69 M

What is the all time high annual CFO for MaxCyte?

MaxCyte all-time high annual cash flow from operations is -$180.50 K

What is MaxCyte annual CFO year-on-year change?

Over the past year, MXCT annual cash flow from operations has changed by -$6.90 M (-46.70%)

What is MaxCyte quarterly cash flow from operations?

The current quarterly CFO of MXCT is -$4.39 M

What is the all time high quarterly CFO for MaxCyte?

MaxCyte all-time high quarterly cash flow from operations is $981.00 K

What is MaxCyte quarterly CFO year-on-year change?

Over the past year, MXCT quarterly cash flow from operations has changed by +$3.85 M (+46.70%)

What is MaxCyte TTM cash flow from operations?

The current TTM CFO of MXCT is -$18.81 M

What is the all time high TTM CFO for MaxCyte?

MaxCyte all-time high TTM cash flow from operations is -$4.43 M

What is MaxCyte TTM CFO year-on-year change?

Over the past year, MXCT TTM cash flow from operations has changed by +$9.95 M (+34.59%)